The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01256970|
Recruitment Status : Completed
First Posted : December 9, 2010
Last Update Posted : September 11, 2013
|Condition or disease|
|Polycystic Ovary Syndrome|
|Study Type :||Observational|
|Actual Enrollment :||306 participants|
|Official Title:||The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire|
|Study Start Date :||November 2010|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||January 2013|
Polycystic Ovary Syndrome.
Polycystic ovary syndrome was diagnosed according to the 2003 Rotterdam criteria, which require a minimum of two of the following three criteria: PCOM, chronic anovulation and hyperandrogenism.
Normal control women were women who did not present with any of three PCOS criteria.
- Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome. [ Time Frame: Prospectively study in University teaching hospital from 31 August 2010 to 31 August 2011. ]To evaluate the contribution to glucose intolerance and metabolic syndrome of obesity combined with the diagnostic criteria of polycystic ovary syndrome (PCOS).
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01256970
|Taipei Medical University-WanFang Hospital|
|Principal Investigator:||Ming-I Hsu||Taipei Medical University WanFang Hospital|